Feline Hemp Extract Compositions With Controlled Cannabinoid Ratios
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of optimal pharmacological treatments for pets, particularly felines, to address pain, epilepsy, and other ailments, with many pet owners seeking potentially efficacious cannabinoids like CBD and CBG for health benefits.
Innovation Solution
Formulating pharmaceutical compositions for felines containing specific ratios of cannabinoids such as cannabidiol to cannabidiolic acid and cannabigerol to cannabigerolic acid, along with other compounds like Δ9-tetrahydrocannabinol and cannabichromene, in oral formulations like chews and pastes, to provide therapeutic benefits without psychotropic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cannabinoids are administered to felines to treat pain and other ailments, then therapeutic efficacy is improved, but risk of psychotropic effects increases
Solution Approach 1:
The patent applies parameter changes by precisely controlling the ratio of cannabidiol to cannabidiolic acid (from about 0.6:1 to about 1:0.6) and maintaining THC below detectable levels or at insufficient concentrations to produce psychotropic effects. This specific parameter optimization allows the composition to achieve therapeutic efficacy for pain and other ailments while eliminating harmful psychotropic effects in felines.
2Ease of operation
If hemp extract is formulated for oral administration to felines, then ease of administration is improved, but formulation complexity increases
Solution Approach 1:
The patent employs composite materials by formulating hemp extract containing multiple cannabinoids (cannabidiol, cannabidiolic acid, and optionally other cannabinoids) in specific ratios with therapeutic efficacy. This composite formulation approach simplifies administration through oral routes (chews, treats, or mixed with food) while the complexity is managed through standardized formulation protocols that ensure consistent cannabinoid ratios and THC levels below psychotropic thresholds.
Data Source
AI summary
Provided herein are pharmaceutical compositions and dosage forms comprising hemp extract that are formulated for oral administration to a feline. Also provided are therapeutic methods using the pharmaceutical compositions and dosage forms.